Navigation Links
Life Sciences Discovery Fund helps launch 3 programs to advance health research and development
Date:6/28/2011

SEATTLE, Washington, JUNE 27, 2011 The Life Sciences Discovery Fund (LSDF) today announced awards to three multi-institutional teams to support development of improved therapies and key resources for medical researchers and health-care policymakers. LSDF will allocate up to $8 million among the three programs.

The programs will be led by University of Washington investigators in partnership with collaborators across the state. Dr. David Flum will work with health-care providers, insurers, and information technology experts to create databases of clinical practices, patient outcomes, and medical costs that can be used to assess the comparative effectiveness and cost effectiveness of specific health-care strategies. This work builds upon an LSDF project grant that Dr. Flum received in 2007.

A second program, led by Dr. Michael Schwartz, will develop new human stem cell-based treatments for type 1 diabetes that avoid the problems of tumor formation and immune rejection that have previously limited the use of such therapies. The research team anticipates that their treatment approach can ultimately be applied to other diseases.

The third program, directed by Dr. John Slattery, will establish a system for collection and statewide distribution of human biological specimens required to answer important research questions and ultimately improve disease diagnosis and treatment. The specimens will be linked to biologically relevant data on the donors, and the program will be constructed to protect patient privacy and rights. This program will complement the cancer biospecimen resource that Dr. Peggy Porter of the Fred Hutchinson Cancer Research Center is developing under an LSDF 2009 program grant.

The three awards were made in the 2010 program grant competition, which supports the launch of new collaborative initiatives that address major health problems and position organizations for future competitiveness and leadership.

According to LSDF executive director Lee Huntsman, the new cohort of awards is anticipated to reap health and economic impacts that are broad in both magnitude and scope. "In addition to improving treatment of a specific conditionnamely, type 1 diabetesthese grants will create robust resources to accelerate development of diagnostics and therapies for a multitude of diseases."

Huntsman added that "the grant to Dr. Flum will allow Washington's health-care community to answer vital questions regarding the value of various treatments and determine the best uses of our limited health-care dollars."

The LSDF board of trustees selected the awardees from 11 proposals that were evaluated by national experts convened by the American Association for the Advancement of Science. In a highly competitive two-phase process, proposals were rated on scientific merit and the potential to improve health and health care in Washington and provide statewide economic benefit.

Lura Powell, chair of the LSDF board of trustees, noted that the impact of the new awards would likely be felt throughout Washington. "These grants support cutting-edge research as well as widespread distribution of high-quality specimens and health-care data. Together, they will help ensure that our state maintains its leadership position in medical research and delivery of cost-effective health care."


'/>"/>

Contact: Alden Jones
aldenj2@uw.edu
206-732-6770
Life Sciences Discovery Fund
Source:Eurekalert

Related biology news :

1. A major prize in the chemical sciences announced by the Camille and Henry Dreyfus Foundation
2. Aerospace sciences meeting to be held Jan. 5-8 in Orlando
3. Natural and social sciences: ICSU embraces the need to work more closely together
4. Energy Biosciences Institue named "Deal of Distinction" by tech-transfer group
5. Elsevier partners with the Royal Netherlands Society for Agricultural Sciences
6. The Danisco Award 2008 goes to D.Sc. Barbara Ann Halkier from Faculty of Life Sciences, Copenhagen
7. Life Sciences Discovery Fund awards health research program grants
8. Springer expands its portfolio in plant sciences with Phytoparasitica
9. Mycotoxin Research joins Springers life sciences journals program
10. NTU seals global partnerships on environmental sciences R&D
11. The Earth Observatory of Singapore devoted to the study of earth sciences officially opens
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/11/2016)... 11, 2016 --> ... report "Image Recognition Market by Technology (Pattern Recognition), by ... by Deployment Type (On-Premises and Cloud), by Industry Vertical ... by MarketsandMarkets, the global market is expected to grow ... Billion by 2020, at a CAGR of 19.1%. ...
(Date:3/9/2016)... This BCC Research report provides an overview ... Sequencing (RNA Seq) market for the years 2015, 2016 ... reagents, data analysis, and services. Use this ... market such as RNA-Sequencing tools and reagents, RNA-Sequencing data ... each segment and forecast their market growth, future trends ...
(Date:3/8/2016)... March 8, 2016   Valencell , the ... announced it has secured $11M in Series D ... a new venture fund being launched by UAE-based ... from existing investors TDF Ventures and WSJ Joshua ... continue its triple-digit growth and accelerate its pioneering ...
Breaking Biology News(10 mins):
(Date:5/25/2016)... ... May 25, 2016 , ... Founder of the Fitzmaurice ... surgery and surgery of the hand by the National Board of Physicians and ... above and beyond in his pursuit of providing the most comprehensive, effective treatment ...
(Date:5/25/2016)... ... May 25, 2016 , ... Lady had been battling arthritis ... cruciate ligament in her left knee. Lady’s owner Hannah sought the help of Dr ... veterinary surgeon, to repair her cruciate ligament and help with the pain of Lady’s ...
(Date:5/24/2016)... , ... May 24, 2016 , ... Last week, Callan ... corporate executives and entrepreneurs, held The Future of San Diego Life Science event at ... Diego life science community attended the event with speakers Dr. Rich Heyman, former CEO ...
(Date:5/23/2016)... , May 23, 2016 Zimmer Biomet Holdings, ... healthcare, today announced that its Board of Directors has approved ... the second quarter of 2016. The cash ... about July 29, 2016 to stockholders of record as of ... of dividends are subject to approval of the Board of ...
Breaking Biology Technology: